Original paper
Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report
Abstract
A 53-year-old man was affected by a sporadic metastatic medullary thyroid cancer (MTC), widespread to cervical and mediastinal lymph nodes, lungs, liver, and cerebellum. Over the 10 years from the initial diagnosis, the patient was treated with two tyrosine kinase inhibitors (TKIs) (i.e. vandetanib and lenvatinib off-label). After 1 year from surgery (total thyroidectomy with lymph node dissection of central and left latero-cervical...
Paper Details
Title
Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report
Published Date
Nov 1, 2021
Journal
Volume
32
Issue
11
Pages
1447 - 1449
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History